FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

2.

The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.

3.

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

4.

More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.

5.

An ancient signaling pathway and 20 years of research offer hope for rare cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot